Apalutamide Dose Reduction Does Not Significantly Reduce Ski

Reduced doses of apalutamide did not significantly decrease rates of skin-related adverse effects vs full-dose apalutamide in patients with advanced prostate cancer.

Related Keywords

United States , Hirosaki , Aomori , Japan , American , Japanese , Kyo Togashi , Hirosaki University Graduate School Of Medicine , Department Of Urology , Administration Of Apalutamide , American Urological Association Annual Meeting , Urological Association Annual , Hirosaki University Graduate School , Advanced Prostate Cancer , Aua Annual Meeting , News , Conference , Apalutamide , 2023 American Urological Association Annual Meeting ,